The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19

NCT04347915 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Clevudine
DRUG: Placebo

Sponsor

Bukwang Pharmaceutical